In the News – Why Managed Care Organizations Must Consider the Effect of COVID-19 on MSK Care

This article originally appeared in Managed Healthcare Executive. To read the entire article, please go to the original article page.

All across the country, and in fact globally, musculoskeletal (MSK) care has become difficult if not impossible for most patients to access because of the COVID-19 pandemic. These injuries may be piling up on couches and porches across America as many go without help. Many hospital-based physical therapy (PT) centers and private PT practices have paused providing in-person assessments and care to avoid close personal contact that increases the risk of spreading the virus.

Although access to MSK care has contracted, the urgent need for these services has not. MSK disorders affect half of all American adults, with more than 126 million Americans over the age of 18 reporting being diagnosed with one of these conditions. These disorders have a significant impact on the health and quality of life of those affected, with approximately 18 million reporting an MSK disorder prevents them from performing daily activities, including walking unaided, bathing, and using the bathroom.

Beyond the pain and limitations experienced by individuals, MSK disorders also exact a high economic cost, affecting employers in every industry as well as insurers:
• MSK disorders account for $213 billion in direct and indirect costs, according to a CDC survey
• Back and neck pain alone are responsible for 290.8 million lost workdays, according to one study.
• Employers spend $20 billion a year on MSK disorders, accounting for 17% of their total healthcare budgets.
• Direct medical expenses cost payers a total of $130 billion.

These numbers are projected to continue to grow substantially as the number of older Americans increases.

Read more of the original article on Managed Healthcare Executive.